Drrx stock forecast.
DURECT has an Altman Z-Score of -16.45 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. -16.45. Piotroski F-Score. 2. Detailed statistics for DURECT Corporation (DRRX) stock, including valuation metrics, financial numbers, share information and more.
What this means: InvestorsObserver gives Durect Corp (DRRX) an overall rank of 37, which is below average. Durect Corp is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 37 means that 63% of stocks appear more favorable to our system.Nov 13, 2023 · Nevertheless, the stock market reaction to the news is punishing, with a ~80% drop in the stock price (from $2.58 to $0.53), which was quickly followed by HC Wainwright's downgrade. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for AYRO Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate ...... DURECT · Dutch Bros · D-Wave Quantum · DXC Technology Company · DXP Enterprises · Dyadic International · Dycom Industries · Dynagas LNG Partners LP · Dynatrace.
Durect Stock Prediction. MAC. 70Durect Stock Prediction. MAC. 70
Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...
DRRX Overview Stock Screener Earnings Calendar Sectors Nasdaq | DRRX U.S.: Nasdaq Durect Corp. Watch list NEW Set a price target alert Open Last Updated: Nov 24, 2023 1:00 p.m. EST Real...Nevertheless, the stock market reaction to the news is punishing, with a ~80% drop in the stock price (from $2.58 to $0.53), which was quickly followed by HC Wainwright's downgrade.Get the latest Microvast Holdings Inc (MVST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.for development and commercialization in other countries. ****CYTR (T/$10) scleroderma etal... DRRX (T/$3) Durect Corp... ... But don't expect its stock price to ...DRRX stock has a “B” rating in the Portfolio Grader. Dynavax Technologies (DVAX) Dynavax Technologies DVAX is a commercial-stage biotech company focusing is on getting drugs over the finish line (approval from the Food & Drug Administration and other regulators in other countries) and available for sale.
Dec 1, 2023 · DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an ...
DRRX Stock Performance on November 8, 2023: On November 8, 2023, DRRX stock had a volatile day of trading. The stock opened at $0.83 and traded in a range of $0.58 to $0.83 throughout the day. The trading volume was 693,861 shares. DRRX is a pharmaceutical company based in Cupertino, California, with a market capitalization of $75.3 million.
Nov 24, 2023 · DRRX Signals & Forecast. There are mixed signals in the stock today. The Durect Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. Analyst Price Forecast Suggests 611.06% Upside. As of ... The put/call ratio of DRRX is 2.39, ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K shares representing 27.10% ...The 4 analysts offering 1 year price forecasts for DRRX have a max estimate of — and a min estimate of —. Analyst rating Based on 4 analysts giving stock ratings to DRRX in the past 3 months. Analyst Price Forecast Suggests 611.06% Upside. As of ... The put/call ratio of DRRX is 2.39, ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K shares representing 27.10% ...Nov 14, 2023 · Durect Corp (NASDAQ:DRRX) has a beta value of 1.29 and has seen 1.24 million shares traded in the last trading session. The company, currently valued at $14.51M, closed the last trade at $0.53 per share which meant it -0.87% during that session. The DRRX stock price is -1692.45% off its 52-week high ... Jul 20, 2023 · /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant. On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trial
Dec 1, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00. Wall Street Analysts Think Durect (DRRX) Could Surge 594.98%: Read This Before Placing a Bet Zacks - Thu May 11, 8:55AM CDT . The mean of analysts' price targets for Durect (DRRX) points to a 595% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in... Get the latest Marker Therapeutics Inc (MRKR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Nov 8, 2023 · DRRX Stock Performance on November 8, 2023: On November 8, 2023, DRRX stock had a volatile day of trading. The stock opened at $0.83 and traded in a range of $0.58 to $0.83 throughout the day. The trading volume was 693,861 shares. DRRX is a pharmaceutical company based in Cupertino, California, with a market capitalization of $75.3 million. Durect Stock Prediction. MAC. 70DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.
The DRRX shares have gain 15.52% over the last week, with a monthly amount drifted -79.02%, and not seem to be holding Durect Corp [DRRX] stock prices are up 0.44% to $0.61 at the moment. One of the good ways to gauge the recent performance is if the stock's short-term value is rising or falling.The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ...
Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite.If you’re looking for stocks under $10 to buy, you can do a lot worse than these highly-rated picks. BBAI BigBear.ai $4.05 APPH AppHarvest $0.95 DRRX Durect 5.18 AUVI Applied UV $1.13 ARDX ...Get the latest TG Therapeutics Inc common stock (TGTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Elys delivers a true state-of-the-art betting platform, capable of processing any type of digital game content. From integrated sports and virtual betting solutions to any third-party content including online casino & slot games, poker, bingo, lottery plus all types of interactive games, we have decades of experience offering it all.. The difference is the Elys’ …Let’s speak about penny stocks. These are equities that commerce for lower than $5 per share, on the very backside of the value vary. Whereas they’re priced that low for a purpose – and the explanations might fluctuate – a low value in itself doesn’t imply that the inventory’s fundamentals are bitter. Sensible buyers can …1 equities research analysts have issued 1 year price targets for Cassava Sciences' shares. Their SAVA share price targets range from $11.00 to $124.00. On average, they predict the company's share price to reach $54.33 in the next year. This suggests a possible upside of 154.5% from the stock's current price.View the latest Lakeland Financial Corp. (LKFN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
(See DRRX stock forecast) Ovid Therapeutics . Next up is Ovid Therapeutics, a biopharmaceutical company working to develop new medications for the treatment of rare neurological disorders, ...
Durect (DRRX) In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Durect, with a price target of $44.00 . The company’s shares closed last Wednesday at ...
Mar 24, 2023 · DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader. Wall Street Analysts Think Durect (DRRX) Could Surge 594.98%: Read This Before Placing a Bet Zacks - Thu May 11, 8:55AM CDT . The mean of analysts' price targets for Durect (DRRX) points to a 595% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in... Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Find the latest Galera Therapeutics, Inc. (GRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Based on analysts offering 12 month price targets for DRRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. For DURECT stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average DURECT stock forecast of $0.99, a high forecast of $1.6, and a low …Durect Corp (DRRX) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See …In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...
Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock.Nov 24, 2023 · DRRX Signals & Forecast. There are mixed signals in the stock today. The Durect Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year.Instagram:https://instagram. nasdaq svramt5 stock brokerbest mobile app for stock marketcalloway golf stock DURECT Corporation Stock Forecast. The DURECT Corporation Stock Prediction is based on short term trend analysis and is best used for short term swing traders or day traders rather than long term investors.. Get DRRX Trend Analysis DRRX Stock Analysis. DRRX is currently in an uptrend. DRRX is up 0.00% on 11/17/23 and has gained a total … discover student loanfedvip cost for military retirees Stock Price Forecast The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 34.50, with a high estimate of 44.00 and a low estimate of 32.00. The median estimate represents a +984.91% increase from the last price of 3.18.Analyst Price Forecast Suggests 611.06% Upside. As of ... The put/call ratio of DRRX is 2.39, ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K shares representing 27.10% ... nasdaq viri Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-BrainerShares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets .../PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant.